Annexin A10 expression in colorectal cancers with emphasis on the serrated neoplasia pathway

Figure 1 Representative images of immunohistochemical staining for Annexin A10. A: Colorectal cancers (CRCs) with Annexin A10 expression (magnification × 200); B: CRCs without Annexin A10 expression (magnification × 200).

Figure 2 Frequency of Annexin A10 expression according to four molecular subtypes. CIMP-N: CpG island methylator phenotype-negative; CIMP-P: CpG island methylator phenotype-positive; MSS: Microsatellite stable; MSI: Microsatellite instability.

Figure 3 Univariate survival analysis in colorectal cancers according to Annexin A10 expression status. A: Overall survival; B: Progression-free survival. ANXA10-; Annexin A10 no-expression, ANXA10+: Annexin A10 expression.

Figure 4 Stage-specific survival analysis according to Annexin A10 expression status. A: Overall survival for Stages I-III colorectal cancers (CRCs); B: Progression-free survival of Stages I-III CRCs; C: Overall survival of Stage IV CRCs; D: Progression-free survival of Stage IV CRCs. ANXA10-; Annexin A10 no-expression, ANXA10+: Annexin A10 expression.